Dna262 发表于 2025-3-25 05:15:15

Submitted on: 23 November 1998.
Revised on: 02 February 1999.
Accepted on: 16 February 1999.

___________________International Journal of Pharmaceutics

appall 发表于 2025-3-25 11:30:28

http://reply.papertrans.cn/2/140/13941/13941-22.png

阻塞 发表于 2025-3-25 15:15:44

Submitted on: 13 June 2009.
Revised on: 03 July 2009.
Accepted on: 21 July 2009.

___________________International Journal of Pharmaceutics

Infusion 发表于 2025-3-25 19:06:49

Submitted on: 01 April 2008.
Revised on: 09 July 2008.
Accepted on: 25 July 2008.

___________________International Journal of Pharmaceutics

arbiter 发表于 2025-3-25 21:42:36

Submitted on: 31 March 2015.
Revised on: 22 April 2015.
Accepted on: 05 May 2015.

___________________International Journal of Pharmaceutics

粗野 发表于 2025-3-26 01:05:50

Submitted on: 15 January 1998.
Revised on: 24 April 1998.
Accepted on: 23 June 1998.

___________________International Journal of Pharmaceutics

该得 发表于 2025-3-26 08:18:11

Submitted on: 21 May 2005.
Revised on: 23 August 2005.
Accepted on: 13 September 2005.

___________________International Journal of Pharmaceutics

Decibel 发表于 2025-3-26 08:49:42

Submitted on: 24 November 2004.
Revised on: 25 January 2005.
Accepted on: 02 March 2005.

___________________International Journal of Pharmaceutics

宪法没有 发表于 2025-3-26 15:29:29

Submitted on: 21 August 2015.
Revised on: 25 September 2015.
Accepted on: 31 October 2015.

___________________International Journal of Pharmaceutics

争论 发表于 2025-3-26 18:20:41

http://reply.papertrans.cn/2/140/13941/13941-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊International Journal of Pharmaceutics 2024/2025影响因子:5.363 (INT J PHARMACEUT) (0378-5173). (PHARMACOLOGY & PHARMA